MedTrace Logo

Clinical Trial Multi-analyte Blood Test

NCT03694600 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1900

Last updated 2024-05-31

No results posted yet for this study

Summary

This is a clinical trial designed to evaluate the performance of a multi-analyte blood test alone to ultrasound alone for the detection of HCC within a population that is at high risk for HCC due to liver cirrhosis.

Conditions

Interventions

DIAGNOSTIC_TEST

Multi-analyte blood Test

intended for the qualitative detection of DNA methylation profiles associated with hepatocellular carcinoma in cell-free DNA derived from patient whole blood specimens.

Sponsors & Collaborators

  • Helio Genomics

    lead INDUSTRY

Principal Investigators

  • Taggart, PhD · Helio Genomics

Eligibility

Min Age
21 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-04
Primary Completion
2023-02-01
Completion
2024-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03694600 on ClinicalTrials.gov